Testing a Provider-Level Feedback Intervention to Optimize Postoperative Prescribing - Aim 3 Phase 1
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Opioid Prescribing
- Sponsor
- University of Michigan
- Enrollment
- 217
- Locations
- 1
- Primary Endpoint
- Change in Opioid Prescribed Following the Intervention
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The objective of this project is to leverage the Michigan Surgical Quality Collaborative's (MSQC) existing network and surgeon performance feedback platform to improve opioid prescribing practices for surgeons within the network found to be prescribing in a manner discordant with published guidelines and to inform best practices for future surgical quality improvement initiatives.
The study is being completed to learn more about the effectiveness, feasibility, and acceptability and that the goal is both to evaluate how effective this intervention and mechanism are for changing surgeon opioid prescribing behavior and to inform best practices for future quality initiatives. The study hypothesizes that provider-level feedback will allow clinicians to tailor postoperative prescribing more closely to patient consumption, and reduce excess postoperative prescribing.
The cohort of surgeons which have been identified as outliers by the Michigan Surgical Quality Collaborative (MSQC) will be be invited to participate in this trial. The study team will send surgeons belonging to sites that signed the Exhibit B-1 form the provider-level push notifications (98 participants). In this study de-identified prescribing data will also be analyzed for sites that do not sign the Exhibit B-1 form (105 participants).
The study team will approach 98 surgeons receiving the provider-level push notifications in one wave.
Investigators
Jennifer Waljee
Associate Professor of Surgery and Associate Professor of Orthopaedic Surgery
University of Michigan
Eligibility Criteria
Inclusion Criteria
- •Surgeons already participating in and sharing data with the Michigan Surgical Quality Collaborative (MSQC) who perform procedures of interest
- •Surgeons within MSQC who have median prescribing \> 1 pill equivalents over the published recommendation
- •Surgeons within MSQC who perform surgeries at a hospital that have agreed to participate in this research
Exclusion Criteria
- •Surgeons not identified in the MSQC data as having a valid National Provider Identifier (NPI)
Outcomes
Primary Outcomes
Change in Opioid Prescribed Following the Intervention
Time Frame: up to 5 months from enrollment
Oral morphine equivalents prescribed adjusted for surgery type as reported through MSQC data.